Lactulose Mylan Pharma

Quick links

Choose a section

Quick links to important sections

Advertisements

Lactulose Mylan Pharma

Advertisements
Advertisements

Overview of Lactulose Mylan Pharma

Quick Facts

Property Description
Active ingredient Lactulose (Synthetic disaccharide)
Form Oral solution or Syrup
Pharmacological class Osmotic laxative; Nitrogen-binding agent
Common purpose Softening of stools and maintaining bowel function
Origin Synthetic (Manufactured sugar derivative)

What Type of Medicine is Lactulose Mylan Pharma?

Lactulose Mylan Pharma is a pharmaceutical preparation that belongs to the class of osmotic laxatives, with the active substance being Lactulose. This specific brand is manufactured and distributed by Mylan Pharma, providing a widely available formulation. The medicine is categorized as a non-systemic agent, meaning its primary therapeutic effect occurs locally within the gastrointestinal tract and is not significantly absorbed into the general circulation. Lactulose is clinically recognized for its function as both a laxative and a colonic acidifier, a role integral to its actions beyond simple stool movement.


Lactulose Composition, Form, and Origin

The sole active ingredient is Lactulose (INN), which is chemically defined as a synthetic disaccharide formed from the simple sugars galactose and fructose. As a manufactured sugar derivative, it is intentionally non-absorbable, ensuring it resists breakdown by human digestive enzymes in the small intestine. This characteristic ensures that the medicine works gently and locally. The preparation is typically available as an oral solution or syrup, a liquid formulation dissolved in an aqueous solution base, designed for oral administration, positioning it as an accessible treatment for adults and children.


General Purpose of Lactulose

The general purpose of Lactulose is to help restore and maintain normal bowel function, offering a pharmacologically supported solution for promoting intestinal movement and stool softening. Its primary mechanism involves osmotic activity, where the unabsorbed sugar draws water into the colon, increasing the bulk and hydration of the stool. Furthermore, the breakdown of Lactulose by the gut's natural flora produces acids that slightly lower the colonic pH. This dual action assists in the management of specific nitrogenous toxins, such as ammonia, contributing to its overall benefit.

Regulatory References

  1. Lactulose: MedlinePlus Drug Information
Advertisements

What side effects are possible with Lactulose Mylan Pharma?

Possible Side Effects and Safety Information

Adverse reactions to Lactulose are primarily linked to the gastrointestinal system, reflecting the medicine's localized action as an osmotic laxative. The safety profile is organized by regulatory bodies into system-organ classes and frequency categories.


Frequency-Classified Adverse Reactions

The most commonly observed effects are gastrointestinal. Based on regulatory classification, these effects are grouped by frequency:

Frequency Category Adverse Reactions
Very Common (ge 1/10) Diarrhoea
Common (ge 1/100 to < 1/10) Flatulence, Abdominal pain, Nausea, Vomiting
Uncommon (ge 1/1,000 to < 1/100) Electrolyte imbalance (due to diarrhoea)
Not Known Hypersensitivity reactions, Rash, Pruritus, Urticaria

Flatulence, or excessive gas, is often noted to occur during the first few days of treatment but typically resolves spontaneously.


Serious Adverse Reactions and Safety Considerations

The main clinically significant risk documented is the potential for electrolyte imbalance and fluid loss resulting from excessive or chronic, unadjusted use leading to severe diarrhoea. Hypersensitivity reactions, including rash, pruritus, and urticaria, are also officially listed as possible adverse effects.

Regulatory documents outline specific safety restrictions. Lactulose is contraindicated in patients with galactosemia and those presenting with gastro-intestinal obstruction or a risk of digestive perforation. For long-term use exceeding six months, particularly in the management of hepatic encephalopathy, periodic monitoring of serum electrolytes (e.g., potassium) is indicated in the official labeling.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

An overdose of the lactulose solution is officially documented to result from excessive dosage, leading to manifestations that are an exaggeration of the medicine's primary effect. The expected clinical presentation listed in regulatory documents includes the onset of persistent diarrhea and abdominal cramps. The primary serious consequence of overdosage is the resulting severe fluid loss and subsequent electrolyte imbalance, particularly hypokalemia (low potassium), which requires corrective measures.


When to Seek Urgent Medical Help

Immediate action involves the cessation of the medicine or an immediate dose reduction. However, urgent medical attention must be sought if unmanaged, severe diarrhea or vomiting occurs, leading to signs of extensive fluid loss. This is critical because the required official management for severe overdosage involves symptomatic and supportive treatment, including the correction of fluid loss and monitoring and correction of electrolyte disturbances.


Population-Specific Regulatory Note

The risk of developing hypokalemia is particularly noted in official labeling for its potential to aggravate underlying Hepatic Encephalopathy in susceptible patients. Additionally, elderly or frail patients are noted to be highly susceptible to clinically significant dehydration and electrolyte disorders due to sustained fluid loss. No specific antidote for lactulose overdose is known.

Advertisements

Therapeutic Uses of Lactulose Mylan Pharma

Quick Facts

  • Chronic Constipation: Supports the management of chronic constipation by helping to soften stools and increase the frequency of bowel movements.
  • Hepatic Encephalopathy (HE): Utilized for the prevention and treatment of a complex condition associated with severe liver disease, including the early and advanced stages.

Lactulose Mylan Pharma is used to support the management of certain gastrointestinal and liver-related conditions, as determined by a healthcare provider.

It is an established therapeutic option for chronic constipation. For individuals with a history of long-lasting constipation, therapy is employed to increase the total number of bowel movements and the number of days on which they occur. The medication is formulated to help increase stool water content, thereby promoting softer stools and facilitating passage.

Additionally, this medication is utilized as an adjunct treatment for the prevention and management of hepatic encephalopathy (HE). This includes pre-coma and coma stages. This application involves helping to reduce blood ammonia levels, which may help support an improved mental state for patients with this condition.

Consult a healthcare professional for a complete therapeutic overview and to confirm if this medication is appropriate for your specific health needs.

Regulatory References

  1. NIH MedlinePlus guidance
Advertisements

Eligibility and Restrictions for Use

This section summarizes the official population eligibility and non-eligibility information for Lactulose Mylan Pharma based on regulatory documentation.

Who Must Not Use This Medicine (Contraindications)

Lactulose Mylan Pharma is contraindicated and must not be used by patients with the following conditions or characteristics:

  • Galactosaemia (a rare hereditary disorder of galactose metabolism).
  • Gastrointestinal Obstruction (other than simple constipation) or a risk of perforation.
  • Known hypersensitivity (allergy) to lactulose or any of its residual sugars, such as lactose, galactose, or fructose.

Populations Requiring Caution or Restriction

Population Category Regulatory Eligibility Status
Infants and Children Use should be exceptional and administered only under medical supervision. Safety and efficacy in children for the treatment of hepatic encephalopathy are not established by regulatory bodies.
Pregnancy and Breastfeeding Use is generally considered permissible if clearly needed, as systemic absorption is negligible and no adverse effects are anticipated.
Diabetics Use with caution, especially at high doses (such as those used for hepatic encephalopathy), as the residual sugar content must be considered.
Patients with Pre-existing GI or Metabolic Issues Caution is needed in patients with painful abdominal symptoms of undetermined cause or those with rare hereditary problems of fructose or galactose intolerance.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Lactulose is minimally absorbed into the bloodstream, meaning its interaction profile is largely based on its local activity within the digestive system, rather than systemic metabolic pathways.

Officially documented interaction patterns primarily involve effects on fluid balance, colonic acidity, and intestinal transit time. Co-administration with certain substance classes requires consideration as detailed in regulatory documents:


Pharmacodynamic and Fluid Balance Interactions

Substance Class Interaction Outcome (Regulatory Description)
Potassium-Losing Agents (e.g., diuretics, corticosteroids, amphotericin B) Co-administration may enhance the loss of potassium (hypokalaemia).
Cardiac Glycosides Increased effect of glycosides due to potential for potassium deficiency when high doses of lactulose are used.
Other Laxatives Increased risk of excessive laxation and resulting fluid and electrolyte disturbances.

Physicochemical and Oral Exposure Interactions

Substance Class Interaction Outcome (Regulatory Description)
Nonabsorbable Antacids May inhibit the desired reduction of colonic pH that is critical for lactulose's full effect in some conditions.
Drugs with pH-Dependent Release The pH changes induced by lactulose can potentially alter the release or efficacy of medicines requiring a specific colonic pH for action.

For all orally administered medications, the effect of accelerated intestinal transit time caused by lactulose must be considered, as this may lead to a reduction in the total exposure of co-administered medicines, a factor relevant to administration separation.

Advertisements

Mechanism of Action

Lactulose is a synthetic disaccharide, a beta-galactofructoside, that remains largely unabsorbed in the upper gastrointestinal tract due to the absence of appropriate disaccharidases in the small intestine. The intact molecule selectively passes to the colon, which serves as its primary site of action.

Upon reaching the colon, lactulose acts as a fermentable substrate for resident colonic bacteria (gut flora). This microbial catabolism yields various organic acids, predominantly lactic acid and acetic acid. This fermentation achieves two major physiological consequences.

First, the presence of these osmotically active metabolites and the unmetabolized lactulose itself increases the osmotic pressure within the intestinal lumen. This gradient facilitates the influx of water into the colon, leading to an increase in the liquid volume of the colonic contents. The organic acids also stimulate colonic peristalsis, promoting the transit of materials.

Second, the organic acid production lowers the colonic pH. This acidification modulates the chemical equilibrium of NH3 and NH4^+. The lower pH favors the conversion of systemic ammonia ( NH3) into the non-absorbable ammonium ion ( NH4^+), a process known as ion trapping, preventing its systemic reabsorption and facilitating its elimination through the feces.

Advertisements

Dosage and Administration Information

Lactulose Mylan Pharma is an oral solution used to treat chronic constipation and portal-systemic encephalopathy (PSE), including the stages of hepatic pre-coma and coma. The product works by increasing the water content of the stool for a laxative effect, which may require 24 to 48 hours to achieve a normal bowel movement.

General Administration

  • The dose may be taken once daily, for example, during breakfast, or divided into two or three doses.
  • Measure the dosage using a suitable measuring device; do not use a standard kitchen spoon.
  • The solution can be swallowed undiluted or mixed with a drink, such as water, fruit juice, or milk, to improve the taste.
  • It is essential to drink sufficient fluids (approximately 6-8 glasses of water or other liquids) daily while on this treatment.

Recommended Adult Dosage

Dosage must be strictly individualized based on the patient's condition and the desired clinical response, as advised by a healthcare provider.

Indication Initial Daily Dose (Lactulose 10 g/15 mL solution) Goal of Therapy
Constipation 15–30 mL (1–2 tablespoons) daily Production of a soft, comfortable stool
Hepatic Encephalopathy 30–45 mL (2–3 tablespoons) 3–4 times daily Maintenance of two to three soft stools daily

For hepatic encephalopathy, the maintenance dose is adjusted every 1–2 days to meet the target of 2–3 soft stools daily. If the initial dose for constipation does not produce results, it may be increased up to 60 mL daily under a doctor’s supervision.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Lactulose Mylan Pharma

Research Evidence for Chronic Constipation

Research exploring the use of Lactulose for chronic constipation primarily relies on Randomized Controlled Trials (RCTs) and systematic reviews. This evidence is part of the research exploring symptom patterns in conditions characterized by fluctuating or episodic manifestations. Adults with chronic functional constipation were included in studies; research also involved children. Researchers monitored outcomes related to physical discomfort and functional measures, such as tracking changes in weekly bowel movement frequency and observing stool consistency using standardized scales.

Studies monitored measurements of stool frequency during the study period compared to control groups. Research highlights measured changes in stool consistency. Data from comparative trials described variable patterns when Lactulose was evaluated alongside other osmotic laxatives; some studies reported observations related to the timing of initial bowel movement. However, evidence quality varies across studies, and comparative evidence against certain newer osmotic laxatives is not always definitive, indicating that data are still emerging in some areas of comparison.

Research Evidence for Hepatic Encephalopathy (HE)

The evidence base for Hepatic Encephalopathy (HE), including pre-coma and coma stages, has been explored using RCTs and systematic reviews. Lactulose was studied for both the acute management of HE episodes and for the prevention of recurrence. This evidence was collected in trials assessing short-term or episodic symptom patterns linked to systemic or functional imbalance.

Studies monitored specific outcomes reflecting daily functioning or activity level, such as neurological status assessments, often using standardized scoring systems. Research also examined changes in physiological markers, specifically focusing on measured levels of ammonia in the blood. Studies report how symptoms evolved in the observed populations, including assessments of mental status and measured blood ammonia levels.

Due to the nature of HE, studies using contemporary, large-scale, placebo-controlled designs may be scarce, especially for acute management. This means that comparative evidence against other standard therapies or combination regimens is frequently the focus of recent research. Findings were mixed in some comparative trials, and research highlights that long-term effects are not fully established across all outcomes, especially regarding survival rates linked solely to Lactulose.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Lactulose Mylan Pharma (FAQ)

Q: How quickly should I expect Lactulose Mylan Pharma to start working?

Regulatory documents state that it may require 24 to 48 hours for the medicine to produce the desired bowel movement. The solution works on the colon, and this time frame is often needed for the medicine to pass through the digestive system and for the effect to fully develop.

Q: Is it normal to feel bloated or gassy after starting Lactulose Mylan Pharma?

Official product information describes that initial dosing is often associated with temporary flatulence and intestinal cramps. These effects are related to the way the medicine is broken down by bacteria in the colon, which produces gas.

Q: Why does Lactulose Mylan Pharma sometimes cause diarrhea?

Diarrhea is an expected result if excessive dosing is administered. Official product labeling states that taking too much may cause diarrhea, which can sometimes lead to fluid loss and potential imbalances in electrolytes (salts) in the body.

Q: Does Lactulose Mylan Pharma affect blood sugar levels?

The solution contains small amounts of related sugars, such as galactose and lactose, as impurities from the manufacturing process. Because of this, regulatory documents advise that the product should be used with caution in individuals who have diabetes.

Q: Is Lactulose Mylan Pharma recommended for people with lactose intolerance?

Official product information advises care when administering the medicine to people who have a known intolerance to lactose. This is because the solution contains small, trace amounts of lactose and other sugars.

Q: Is Lactulose Mylan Pharma suitable for long-term management of liver disease symptoms?

The drug is indicated for the management of hepatic encephalopathy, which is often a chronic condition. Regulatory documents note that in elderly or weakened patients receiving the solution for more than six months, periodic measurement of serum electrolytes may be required, which suggests that extended use is a factor for medical consideration.

Q: Is there a maximum period of time for using Lactulose Mylan Pharma, according to official documents?

Official guidance does not generally specify an exact maximum duration of use. However, regulatory information indicates that for elderly or debilitated patients receiving the solution for periods longer than six months, regular monitoring of blood electrolyte levels may be necessary to ensure safety.

Q: Can taking too much Lactulose Mylan Pharma cause dehydration?

Overdosage is expected to cause diarrhea and abdominal cramps. Because diarrhea results in the body losing too much fluid and salts, excessive dosing is described as being able to lead to fluid loss and potential electrolyte imbalances.

Q: Is Lactulose Mylan Pharma considered a laxative?

The product is an osmotic agent that is officially indicated for the treatment of chronic constipation. Regulatory documents describe its mechanism as promoting laxation (a bowel movement) by drawing water into the stool, making it softer and easier to pass.

Q: Does Lactulose Mylan Pharma treat anything besides constipation?

According to official documents, the product has two primary indications (uses). These are chronic constipation and portal-systemic encephalopathy (PSE), which is a condition affecting the brain due to severe liver disease.

Q: Is Lactulose Mylan Pharma the same as the lactulose I can buy over the counter?

In the United States, the lactulose solution is generally classified by the Food and Drug Administration (FDA) as a prescription-only medication. This classification is primarily related to its use for conditions like hepatic encephalopathy.

Q: Can children use Lactulose Mylan Pharma?

According to US regulatory documents, the safety and effectiveness of this specific lactulose solution for use in pediatric patients (children) has not been formally established. Any consideration for use in children would be determined by a healthcare provider.

Q: Is Lactulose Mylan Pharma safe for use during pregnancy?

Official information states that adequate and well-controlled studies in pregnant women are not available. Therefore, regulatory documents indicate that the drug is to be used during pregnancy only if clearly required, as determined by a healthcare professional.

Q: What happens if I miss a dose of Lactulose Mylan Pharma?

Patient information materials often suggest that if a dose is missed, it should be taken as soon as it is remembered. For guidance on managing a missed dose, consultation with a healthcare provider is generally recommended.

Q: Are there any significant interactions between Lactulose Mylan Pharma and antibiotics?

Some regulatory-linked resources advise discussing the co-administration of certain antibiotics, such as neomycin. Those medicines may potentially affect the drug's action by altering the gut flora necessary for its catabolism.

Q: Does Lactulose Mylan Pharma require a prescription in all countries?

In the United States, the product is classified by the FDA as a prescription drug. The necessity of a prescription varies by country.

Q: Is Lactulose Mylan Pharma habit-forming or does it cause dependency?

In the United States, the product is not classified as a controlled substance and is not listed on the Drug Enforcement Administration's (DEA) schedule. This indicates that it is not considered to have a potential for abuse or dependency.

Q: What are the ingredients listed as 'inactive' in Lactulose Mylan Pharma syrup?

Inactive components (excipients) listed in the solution can include purified water, flavoring, FD&C Yellow No. 6, and sodium hydroxide. Sodium hydroxide is used to adjust the acidity level ( pH) of the liquid.

Q: Does this medicine have a particular taste or odor?

The solution is described in regulatory documents as a clear, viscous liquid that is colorless to pale brownish-yellow. Inactive ingredients include added flavoring to help make the medicine more palatable.

Q: Why might a person taking Lactulose Mylan Pharma feel increased thirst?

Increased thirst is an expected symptom associated with potential fluid and electrolyte changes. This could result from excessive dosing and associated diarrhea that leads to a loss of fluids and salts from the body.

Q: Does official research support the use of Lactulose Mylan Pharma for chronic constipation?

Regulatory documents confirm the drug's indication for constipation. Official summaries state that therapy increases the number of bowel movements per day and the number of days on which bowel movements occur in patients with chronic constipation.

Q: Does the time of day I take Lactulose Mylan Pharma matter?

Official administration guidelines describe that the dose may be taken as a single daily amount (such as during breakfast) or divided into two or three doses throughout the day. The instructions do not specify a time of day that is required for effective use.

Q: Can older adults use Lactulose Mylan Pharma without special precautions?

Regulatory information notes that elderly or debilitated patients who receive the solution for periods longer than six months may require periodic monitoring of their blood electrolyte levels. This indicates that monitoring may be a consideration during extended treatment.

Q: What specific groups of patients are officially advised against using this drug?

The solution is officially contraindicated (advised against) for two specific groups of patients. These are individuals who have gastrointestinal obstruction or who must follow a low-galactose diet (a hereditary condition called galactosemia).

Q: Does Lactulose Mylan Pharma need to be refrigerated?

Official product labeling advises storing the solution at controlled room temperature, typically between 20 C and 25 C (68 F and 77 F). The instructions also clearly note that the solution should not be frozen.

Q: Is Lactulose Mylan Pharma absorbed into the bloodstream?

Official data indicates that the drug is poorly absorbed from the digestive tract, with urinary excretion measured at 3% or less of the total dose. Its main site of action is locally within the colon, not systemically in the bloodstream.

Q: What if Lactulose Mylan Pharma doesn't seem to be working after a few days?

Official guidance advises that if the therapeutic effect is insufficient after several days, consulting a physician is recommended. This allows for the situation to be reviewed by a healthcare provider.

Q: What official warnings are related to the use of Lactulose Mylan Pharma?

Official warnings include the contraindication for patients on a low-galactose diet. Another warning mentions a theoretical hazard during certain electrocautery procedures, such as proctoscopy, due to the possibility of hydrogen ( H2) gas accumulation in the colon.

Q: Are there non-diarrhea related side effects mentioned in the drug information?

Officially reported adverse effects that are not diarrhea include flatulence (gas), intestinal cramps (which are usually temporary), nausea, and vomiting. These are generally related to the effects of the medicine within the digestive tract.

Q: Does Lactulose Mylan Pharma contain gluten or common allergens?

The solution contains lactulose, but because of the manufacturing process, it may also contain small amounts of other sugars such as lactose and galactose. For those with allergies or intolerances, reviewing the full ingredient list with a pharmacist or doctor is often advised.

Q: Is the medication designed to affect the balance of gut bacteria?

The product is a fermentable substrate for colonic bacteria. Its mechanism of action is dependent on its microbial breakdown by gut flora (bacteria) in the colon.

Q: How is the safety of Lactulose Mylan Pharma evaluated for nursing mothers?

Regulatory documents state that it is currently not known whether the product is excreted into human milk. Caution is therefore advised when administering the solution to nursing women.

Advertisements

How should Lactulose Mylan Pharma be stored and disposed of?

Storage and Disposal Requirements for Lactulose Oral Solution

Lactulose oral solution must be stored at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). The medicine must be kept out of the sight and reach of children.

Storage Requirement Rule
Temperature Do not freeze or refrigerate. Avoid prolonged exposure above 30 C.
Protection Keep the container tightly closed and protected from direct light.
Integrity Do not use if the solution develops extreme darkening and turbidity.

For disposal, unused or expired Lactulose should not be discarded in wastewater or household trash. The product and waste material must be disposed of in accordance with local requirements, and a pharmacist should be consulted for proper disposal methods.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lactulose Mylan Pharma found in:

A-Z Index: